Ascentage Pharma Group International ASPHF
3.46 USD 0.00 (+0.00%)
At closeNov 3, 2026, 4:00 PM EST
3.46 Day range 3.46
3.46 52-week range 9.32
- YTD
- -59.20%
- 1 year
- -62.88%
- Market cap
- 1.29B
- EPS (ttm)
- -0.56
- YTD return
- -59.20%
- 1-year return
- -62.88%
- Volume
- 100
- Avg volume
- 191
- Open
- 3.46
- Previous close
- 3.46
- Day's range
- 3.46 – 3.46
- 52-week range
- 3.46 – 9.32
- Earnings date
- Aug 26, 2026
2Y +0.77 (+28.62%)
Next earnings
Aug 26, 2026
Expected Aug 26, 2026. Consensus EPS estimate -0.05522.
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Aug 26, 2026 | Jun 30, 2026 | -0.05522 | — | — | — |
| Mar 24, 2026 | Dec 31, 2025 | -0.20929 | -0.16035 | +0.05 | +23.38% |
| Aug 20, 2025 | Jun 30, 2025 | — | -0.24142 | — | — |
| Mar 27, 2025 | Dec 31, 2024 | 0.00411 | 0.00411 | 0.00 | 0.00% |
| Aug 22, 2024 | Jun 30, 2024 | — | 0.07566 | — | — |
| Mar 27, 2024 | Dec 31, 2023 | — | -0.25415 | — | — |
News
Ascentage Pharma Group International (AAPG) Q4 2025 Earnings Call Transcript 
Ascentage Pharma Group International (AAPG) Presents at Guggenheim Securities Emerging Outlook: Biotech Summit 2026 Transcript 
Ascentage Pharma Group International (OTCMKTS:ASPHF) Sees Significant Increase in Short Interest 
Ascentage Pharma Group International (AAPG) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript 
Ascentage Pharma Group International (OTCMKTS:ASPHF) Stock Price Down 23.4% – Should You Sell? 
Ascentage Pharma Group International – Unsponsored ADR (NASDAQ:AAPG) Short Interest Update 
Ascentage Pharma Group International (AAPG) Presents At Citi's Biopharma Back To School Conference Transcript 
Takeda-backed Ascentage Pharma aims to raise $126 mln in US IPO 
Takeda-backed Ascentage Pharma targets $1.75 billion valuation in US IPO 
Ascentage Pharma to Present at 43rd Annual J.P. Morgan Healthcare Conference
Your note
Sign in to keep a note on ASPHF — it syncs with the Stock Master app.